Sofokast Plus

Composition:

Sofokast Plus – Sofosbuvir and daclatasvir

Therapeutic Class:

Hepatitis C medicine

What is Sofokast Plus tablet?

Sofokast Plus is a sofosbuvir and daclatasvir tablet manufactured by Aprazer Healthcare.

Sofokast Plus is widely accepted and prescribed by medical practitioners for its synergetic antiviral efficacy.

Sofokast Plus (sofosbuvir and daclatasvir) tablet uses-

It is effective against multiple strains of hepatitis C.

It is used for chronic hepatitis C.

Aprazer Healthcare – The Hepatitis C Medicine Manufacturer

Aprazer Healthcare is an Indian pharmaceutical manufacturer, manufacturing a diverse range of liver care medicines.

Widely known as a hepatology medicine manufacturer, we specialize in manufacturing hepatitis C medicines.

Manufacturing a diverse range of antiviral drugs, we are recognized for affordable hepatitis C medicines.

Our antiviral product portfolio consists of –

• • Hepatitis B medicines
• • Hepatitis C medicines
• • HIV medicines

How does Sofokast Plus (sofosbuvir and daclatasvir) tablet work?

It consists of 2 drugs.

It offers a synergistic effect.

The combination inhibits the replication /multiplication of the virus.

Sofokast Plus (sofosbuvir and daclatasvir) tablet benefits –

• • It offers potent viral suppression.
• • It has fewer side effects.
• • It can be used with ribavirin.
• • It is effective against multiple strains.
• • It can be used after a liver transplant.
• • It can be used in HIV co-infections.
• • It can be used in liver disorders.

Sofokast Plus (sofosbuvir and daclatasvir) tablet adverse effects-

It is usually well tolerated.

Mild side effects include –

• • Nausea
• • Dizziness
• • Headache
• • Digestive issues
• • Tiredness
• • Diarrhea

Sofokast Plus (sofosbuvir and daclatasvir) tablets severe side effects-

• • Severe bradycardia
• • Heart block
• • Hepatitis B reactivation
• • Severe skin reaction

Why are Sofokast Plus (sofosbuvir and daclatasvir) tablets used cautiously?

It can severely reduce blood count with amiodarone.

Avoid in patients with-

• • Kidney disorders
• • Liver disorder
• • Hepatitis B co-infections

Long–term therapy should be monitored for –

• • Hepatic functions
• • Renal functions
• • Cardiac functions
• • Hepatitis co-infections

When not to use Sofokast Plus (sofosbuvir and daclatasvir) tablets?

It is a prescription medicine.

It cannot be used as monotherapy for HCV infection.

Do not use in-

• • Allergy to a drug
• • Pregnancy
• • Breastfeeding ladies

What to avoid with Sofokast Plus (sofosbuvir and daclatasvir) tablets?

It can increase adverse drug effects.

Avoid with –

• • Antibiotics
• • Anti-seizure medicines
• • Heart medicines